Daiichi Sankyo Company, Limited (DSKYF)

USD 26.5

(0.0%)

Revenue Summary of Daiichi Sankyo Company, Limited

  • Daiichi Sankyo Company, Limited's latest annual revenue in 2024 was 1601.68 Billion JPY , up 25.28% from previous year.
  • Daiichi Sankyo Company, Limited's latest quarterly revenue in 2024 FY was 1601.68 Billion JPY , up 25.28% from previous quarter.
  • Daiichi Sankyo Company, Limited reported a annual revenue of 1278.47 Billion JPY in annual revenue 2023, up 22.36% from previous year.
  • Daiichi Sankyo Company, Limited reported a annual revenue of 1044.89 Billion JPY in annual revenue 2022, up 8.56% from previous year.
  • Daiichi Sankyo Company, Limited reported a quarterly revenue of 1601.68 Billion JPY for 2024 FY, up 25.28% from previous quarter.
  • Daiichi Sankyo Company, Limited reported a quarterly revenue of 446.92 Billion JPY for 2024 Q3, up 19.02% from previous quarter.

Annual Revenue Chart of Daiichi Sankyo Company, Limited (2024 - 2000)

Historical Annual Revenue of Daiichi Sankyo Company, Limited (2024 - 2000)

Year Revenue Revenue Growth
2024 1601.68 Billion JPY 25.28%
2023 1278.47 Billion JPY 22.36%
2022 1044.89 Billion JPY 8.56%
2021 962.51 Billion JPY -1.96%
2020 981.79 Billion JPY 5.6%
2019 929.71 Billion JPY -3.17%
2018 960.19 Billion JPY 0.53%
2017 955.12 Billion JPY -3.18%
2016 986.44 Billion JPY 7.3%
2015 919.37 Billion JPY 2.25%
2014 899.12 Billion JPY -9.6%
2013 994.65 Billion JPY 5.96%
2012 938.67 Billion JPY -2.97%
2011 967.36 Billion JPY 1.6%
2010 952.1 Billion JPY 13.06%
2009 842.14 Billion JPY -4.31%
2008 880.12 Billion JPY -5.31%
2007 929.5 Billion JPY 0.39%
2006 925.91 Billion JPY 57.51%
2005 587.83 Billion JPY -1.43%
2004 596.34 Billion JPY 4.64%
2003 569.92 Billion JPY 3.83%
2002 548.89 Billion JPY 0.7%
2001 545.07 Billion JPY -7.57%
2000 589.73 Billion JPY 0.0%

Peer Revenue Comparison of Daiichi Sankyo Company, Limited

Name Revenue Revenue Difference
AstraZeneca PLC 46.91 Billion USD -3314.043%
Bristol-Myers Squibb Company PFD CONV 2 45 Billion USD -3458.832%
CSPC Pharmaceutical Group Limited 31.45 Billion USD -4992.79%
Clarus Therapeutics Holdings, Inc. 13.95 Million USD -11475775.905%
Novartis AG 46.66 Billion USD -3332.679%
PT Kalbe Farma Tbk. 1.97 Billion USD -80826.288%